Skip to main
ASPN
ASPN logo

Aspen Aerogels (ASPN) Stock Forecast & Price Target

Aspen Aerogels (ASPN) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 58%
Buy 32%
Hold 5%
Sell 5%
Strong Sell 0%

Bulls say

Aspen Aerogels Inc reported record Energy Industrial revenues of $53.1 million in the fourth quarter, reflecting a substantial 70% year-over-year increase, driven by enhanced manufacturing capacity. The company exceeded its annual revenue expectations with a total of $453 million for the year, representing a remarkable 90% year-over-year growth compared to 2023, positioning it favorably for future revenue acceleration. Furthermore, proactive cost management strategies have resulted in a reduced fixed cost base of approximately $8 million per quarter, while a capital-light expansion strategy supports positive cash generation, suggesting a healthy financial outlook moving forward.

Bears say

Aspen Aerogels Inc is experiencing a downward revision in its revenue forecasts, with expectations for Thermal Barrier (TB) revenue projected at $240 million for 2025, a significant decrease from 2024's $306.8 million. The company faces challenges such as an inability to maintain profitability, supply chain disruptions, and reliance on a limited customer base, which raises concerns about future earnings stability. Additionally, the weak guidance for the first quarter and the absence of annual revenue projections indicate low visibility regarding production volumes and present a negative outlook for the company’s financial performance beyond 2025.

Aspen Aerogels (ASPN) has been analyzed by 19 analysts, with a consensus rating of Buy. 58% of analysts recommend a Strong Buy, 32% recommend Buy, 5% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aspen Aerogels and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aspen Aerogels (ASPN) Forecast

Analysts have given Aspen Aerogels (ASPN) a Buy based on their latest research and market trends.

According to 19 analysts, Aspen Aerogels (ASPN) has a Buy consensus rating as of Aug 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.16, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.16, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aspen Aerogels (ASPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.